Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-05

Clinical Trial Update: Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates efficacy and tolerability of new topical formulations for atopic dermatitis. The study, sponsored by Procter & Gamble Beauty, has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Procter & Gamble Beauty | Conditions: Dermatitis, Atopic, Eczema | Phase 4 | Status: COMPLETED